Cytek Biosciences, Inc. CTKB Change in AR
Change in AR at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s change in ar.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s change in AR?
- Cytek Biosciences, Inc. (CTKB) reported change in AR of -$9.65M in Q1 2026.
- How has Cytek Biosciences, Inc.'s change in AR changed year-over-year?
- Cytek Biosciences, Inc.'s change in AR decreased by 49.6% year-over-year, from -$6.45M to -$9.65M.
- What is the long-term trend for Cytek Biosciences, Inc.'s change in AR?
- Over 3 years (2021 to 2024), Cytek Biosciences, Inc.'s change in AR has grown at a -24.0% compound annual growth rate (CAGR), from $12.37M to $5.43M.
- What does change in AR mean?
- Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.